Medical testing startup Theranos has agreed to publish data that it says will validate the accuracy of its blood tests after they were called into question by a Wall Street Journal article published last week.
Theranos Relents, Will Publish Blood Test Data
The biotech startup will try to rebut questions about the accuracy of its tests.
Lisa Lake / Getty Images
Elizabeth Holmes, the billionaire CEO of the rapidly growing company, confirmed that Theranos would make the information public in a bid to quell attacks claiming the company wasn’t using its own technology in its tests. “Data is a powerful thing because it speaks for itself,” she said, speaking at a conference sponsored by the Cleveland Clinic on Monday night. Holmes did not say when or where her company would actually make the information public.
This article originally appeared on Recode.net.
See More:
